Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade
ACS Nano · 2023
DOI: 10.1021/acsnano.2c12313 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Yue Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
- University of Science and Technology of China, Hefei, Anhui 230029, P. R. China.
ORCID-Profile: Jinsong Ren, Xiaogang Qu
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Wei, Y., Qin, G., Wang, Z., Zhao, C., Ren, J., & Qu, X. (2023). Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade. ACS Nano. https://doi.org/10.1021/acsnano.2c12313
Vancouver
Wei Y, Qin G, Wang Z, Zhao C, Ren J, Qu X. Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade. ACS Nano. 2023. doi:10.1021/acsnano.2c12313
BibTeX
@article{Wei2023,
author = {Wei, Yue and Qin, Geng and Wang, Zhao and Zhao, Chuanqi and Ren, Jinsong and Qu, Xiaogang},
title = {Bioorthogonal Activation of TLR7 Agonists Provokes Innate Immunity to Reinforce Aptamer-Based Checkpoint Blockade},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.2c12313}
}
EUVIMED